SEFXIM-TZ PET 562.5
SEFXIM-TZ PET 562.5
(Ceftriaxone & Tazobactam for Injection)
n
Composition:
nEach vial contains:
n
nCeftriaxone Sodium (Sterile)Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â I.P.
n
nEq. to Ceftriaxone                                                     500 mg
n
nTazobactam Sodium (Sterile)Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â I.P.
n
nEq. To Tazobactam                                                    62.5 mg
n
Packaging:
nCombipack contains 1 vial of Ceftriaxone & Tazobactam for Injection 562.5mg & Sterile Water for Injection I.P. 5 ml along with Sterile Disposable Syringe and Needle.
Product Description
Combipack contains 1 vial of Ceftriaxone & Tazobactam for Injection 562.5mg & Sterile Water for Injection I.P. 5 ml along with Sterile Disposable Syringe and Needle.
n
Product Description:
nSEFXIM-TZ PET 562.5 Injection is a potent broad-spectrum veterinary antibiotic formulation combining ceftriaxone and tazobactam, designed for effective management of serious bacterial infections in animals. Ceftriaxone, a third-generation cephalosporin, acts by inhibiting bacterial cell wall synthesis, leading to rapid bactericidal action, while tazobactam functions as a β-lactamase inhibitor, protecting ceftriaxone from enzymatic degradation and extending its activity against resistant pathogens. This synergistic combination ensures enhanced efficacy against a wide range of Gram-positive and Gram-negative organisms, including β-lactamase–producing bacteria.
n
nSEFXIM-TZ PET 562.5 is especially useful in managing mixed and resistant bacterial infections, providing reliable and rapid clinical response in veterinary practice. Its strong antibacterial coverage makes it a preferred choice for veterinarians in treating moderate to severe infections and ensuring better recovery outcomes in animals.
n
Indications:
n
-
n
- Treatment of respiratory tract infections (pneumonia, bronchitis)
- Management of urinary tract infections (UTIs)
- Treatment of skin and soft tissue infections, wounds, and abscesses
- Management of gastrointestinal infections caused by susceptible bacteria
- Treatment of septicemia and systemic infections
- Management of post-surgical infections
- Effective against mixed and resistant bacterial infections
n
n
n
n
n
n
n
n
Therapeutic Segment Positioning:
nAntibiotics (Veterinary)
